• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Tofacitinib relieves symptoms of stimulator of interferon genes (STING)-associated vasculopathy with onset in infancy caused by 2 de novo variants in TMEM173.

作者信息

Seo Jieun, Kang Jung-Ah, Suh Dong In, Park Eun-Byeol, Lee Cho-Rong, Choi Sun Ah, Kim Soo Yeon, Kim Yeji, Park Sang-Heon, Ye Michael, Kwon Soon-Hak, Park June Dong, Lim Byung Chan, Lee Dong Hun, Kang Suk-Jo, Choi Murim, Park Sung-Gyoo, Chae Jong-Hee

机构信息

Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Korea.

Cell Logistics Research Center and School of Life Sciences, Gwangju Institute of Science and Technology, Gwangju, Korea.

出版信息

J Allergy Clin Immunol. 2017 Apr;139(4):1396-1399.e12. doi: 10.1016/j.jaci.2016.10.030. Epub 2016 Dec 29.

DOI:10.1016/j.jaci.2016.10.030
PMID:28041677
Abstract
摘要

相似文献

1
Tofacitinib relieves symptoms of stimulator of interferon genes (STING)-associated vasculopathy with onset in infancy caused by 2 de novo variants in TMEM173.托法替布可缓解由TMEM173基因的2个新发变异导致的婴儿期起病的干扰素基因刺激物（STING）相关血管病的症状。
J Allergy Clin Immunol. 2017 Apr;139(4):1396-1399.e12. doi: 10.1016/j.jaci.2016.10.030. Epub 2016 Dec 29.
2
STING-Associated Vasculopathy with Onset in Infancy in Three Children with New Clinical Aspect and Unsatisfactory Therapeutic Responses to Tofacitinib.婴儿期起病的 STING 相关性血管病伴新型临床特征，托法替尼治疗反应不佳：三例报告
J Clin Immunol. 2020 Jan;40(1):114-122. doi: 10.1007/s10875-019-00690-9. Epub 2019 Nov 8.
3
Tofacitinib Ameliorates Murine Lupus and Its Associated Vascular Dysfunction.托法替尼改善狼疮小鼠及其相关血管功能障碍。
Arthritis Rheumatol. 2017 Jan;69(1):148-160. doi: 10.1002/art.39818.
4
Refractory ulcerations associated with livedoid vasculopathy successfully treated with tofacitinib.托法替布成功治疗与类脂质渐进性坏死性血管病相关的难治性溃疡
Dermatol Ther. 2020 Nov;33(6):e14470. doi: 10.1111/dth.14470. Epub 2020 Nov 16.
5
Alopecia universalis. Partial response to tofacitinib.全秃。托法替布治疗有效。
Med Clin (Barc). 2019 Aug 2;153(3):e15. doi: 10.1016/j.medcli.2018.11.006. Epub 2019 Feb 1.
6
Topical tofacitinib in treatment of alopecia areata.局部应用托法替布治疗斑秃。
Einstein (Sao Paulo). 2020;18:eAI5452. doi: 10.31744/einstein_journal/2020ai5452. Epub 2020 Aug 10.
7
Tofacitinib as a novel salvage therapy for refractory T-cell large granular lymphocytic leukemia.托法替布作为难治性T细胞大颗粒淋巴细胞白血病的一种新型挽救疗法。
Leukemia. 2015 Dec;29(12):2427-9. doi: 10.1038/leu.2015.280. Epub 2015 Oct 9.
8
XELJANZ (Tofacitinib) for Chronic Plaque Psoriasis.XELJANZ（托法替布）用于治疗慢性斑块状银屑病。
Skinmed. 2015 May-Jun;13(3):227-9.
9
Tofacitinib for the treatment of recalcitrant palmoplantar pustulosis: A case report.托法替布治疗顽固性掌跖脓疱病：一例报告。
Australas J Dermatol. 2020 Feb;61(1):e108-e110. doi: 10.1111/ajd.13117. Epub 2019 Jul 18.
10
Tofacitinib therapy for children with severe alopecia areata.托法替布治疗儿童重度斑秃
J Am Acad Dermatol. 2019 Apr;80(4):1164-1166. doi: 10.1016/j.jaad.2018.12.041. Epub 2019 Jan 8.

引用本文的文献

1
Response to two Janus kinase inhibitors in a boy with SAVI during 2-year follow-up: case report and literature review.一名患有自发性自身炎症性血管病（SAVI）的男孩在两年随访期间对两种 Janus 激酶抑制剂的反应：病例报告及文献综述
Front Immunol. 2025 Jul 8;16:1615075. doi: 10.3389/fimmu.2025.1615075. eCollection 2025.
2
Emerging concepts and treatments in autoinflammatory interferonopathies and monogenic systemic lupus erythematosus.自身炎症性干扰素病和单基因系统性红斑狼疮的新兴概念与治疗方法
Nat Rev Rheumatol. 2025 Jan;21(1):22-45. doi: 10.1038/s41584-024-01184-8. Epub 2024 Dec 2.
3
Rare genetic interstitial lung diseases: a pictorial essay.
罕见遗传性肺间质疾病的影像学表现。
Eur Respir Rev. 2024 Nov 13;33(174). doi: 10.1183/16000617.0101-2024. Print 2024 Oct.
4
Unraveling the diagnostic odyssey: stimulator of interferon gene-associated vasculopathy with onset in infancy in a 30-year-old female.解析诊断历程：一名30岁女性婴儿期起病的干扰素基因刺激因子相关血管病
J Rheum Dis. 2024 Jul 1;31(3):182-187. doi: 10.4078/jrd.2023.0075. Epub 2024 Apr 9.
5
A novel STING variant triggers endothelial toxicity and SAVI disease.一种新型 STING 变体引发血管内皮毒性和 SAVI 疾病。
J Exp Med. 2024 Sep 2;221(9). doi: 10.1084/jem.20232167. Epub 2024 Jul 2.
6
Vasculitis and vasculopathy associated with inborn errors of immunity: an overview.与遗传性免疫缺陷相关的血管炎和血管病变：概述
Front Pediatr. 2024 Jan 31;11:1258301. doi: 10.3389/fped.2023.1258301. eCollection 2023.
7
A rare manifestation of STING-associated vasculopathy with onset in infancy: a case report.婴儿期起病的 STING 相关性血管病的罕见表现：病例报告。
Pediatr Rheumatol Online J. 2024 Jan 4;22(1):9. doi: 10.1186/s12969-023-00934-4.
8
Case Report: ISG15 deficiency caused by novel variants in two families and effective treatment with Janus kinase inhibition.病例报告：两个家族中由新型变异引起的 ISG15 缺乏症，以及使用 Janus 激酶抑制的有效治疗。
Front Immunol. 2023 Dec 5;14:1287258. doi: 10.3389/fimmu.2023.1287258. eCollection 2023.
9
Treatment of STING-associated vasculopathy with onset in infancy in patients carrying a novel mutation in the TMEM173 gene with the JAK3-inhibitor tofacitinib.携带TMEM173基因新突变的婴儿期起病的STING相关性血管病患者使用JAK3抑制剂托法替布的治疗
Arch Rheumatol. 2023 Feb 3;38(3):461-467. doi: 10.46497/ArchRheumatol.2023.9927. eCollection 2023 Sep.
10
Case report: JAK1/2 inhibition with baricitinib in the treatment of STING-associated vasculopathy with onset in infancy.病例报告：巴瑞替尼治疗婴儿期起病的 STING 相关性血管病中 JAK1/2 的抑制作用。
Pediatr Rheumatol Online J. 2023 Oct 26;21(1):131. doi: 10.1186/s12969-023-00916-6.